NCT03159533 (IMPACT) is a NA clinical trial of CHW Intervention in Hypertension, sponsored by NYU Langone Health.

Who is sponsoring NCT03159533?

NCT03159533 is sponsored by NYU Langone Health.

What drugs are being tested in NCT03159533?

Interventions in NCT03159533: CHW Intervention, Wait List Control Group.

What condition does NCT03159533 study?

NCT03159533 studies Hypertension.

Is NCT03159533 still recruiting?

NCT03159533 is currently completed. Last updated 18 May 2020.

Last reviewed 2020-05-18 · How we verify

NCT03159533: IMPACT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Project IMPACT: CHW Intervention

Completed NA Last updated 18 May 2020

What this trial tests

NA trial testing CHW Intervention in Hypertension in 305 participants. Completed in 1 July 2019.

Timeline

9 March 2017

Primary endpoint
1 July 2019

1 July 2019

Quick facts

Lead sponsor	NYU Langone Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	305
Start date	9 March 2017
Primary completion	1 July 2019
Estimated completion	1 July 2019
Sites	1 location across United States

Drugs / interventions tested

CHW Intervention
Wait List Control Group

Conditions studied

Hypertension — all drugs for Hypertension →

Sponsor

NYU Langone Health — full company profile →

Who can join

Adults 18 to 85, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed study "Project IMPACT: CHW Intervention" is part of a larger study examining the efficacy, adoption, and impact of integrated EHR-based decision-support and physician feedback interventions with community health worker (CHW)-led self-management and coaching support for South Asian patients with uncontrolled hypertension. This is a randomized control intervention utilizing community health worker (CHW)-led self-management and coaching support for South Asian patients with uncontrolled hypertension at PCP clinics in New York City.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Integrating Community Health Workers into Community-Based Primary Care Practice Settings to Improve Blood Pressure Control Among South Asian Immigrants in New York City: Results from a Randomized Control Trial.
Islam NS, Wyatt LC, Ali SH, Zanowiak JM, et al · · 2023 · cited 26× · PMID 36815464 · DOI 10.1161/circoutcomes.122.009321
Protocol for project IMPACT (improving millions hearts for provider and community transformation): a quasi-experimental evaluation of an integrated electronic health record and community health worker intervention study to improve hypertension management among South Asian patient
Lopez PM, Zanowiak J, Goldfeld K, Wyka K, et al · · 2017 · cited 13× · PMID 29207983 · DOI 10.1186/s12913-017-2767-1

Verify or expand the search:

Other trials of CHW Intervention

Trials testing the same drug.

NCT02041598 — DREAM Project Community Health Worker Intervention · NA · completed

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other NYU Langone Health trials

Trials by the same sponsor.

NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03159533 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
Last refreshed: 18 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03159533.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing